Clinical Trials Logo

Clinical Trial Summary

The goals of this study were two-fold. First, the attempt to quantify the relationships between pulmonary arterial stiffness, right ventricular function and the efficiency of ventricular-vascular interactions in patients with pulmonary arterial hypertension (PAH). Second, the attempt to quantify the effects of exercise on pulmonary arterial stiffness, pulmonary vascular resistance, right ventricular function and the efficiency of ventricular-vascular interactions in patients with PAH.


Clinical Trial Description

The goals of this study are to quantify right ventricular-pulmonary vascular interactions in different types of PAH, to determine the temporal changes in these interactions with PAH progression and to quantify the effects of exercise on right ventricular function. The inclusion of the subpopulation of PAH patients with systemic sclerosis (SSc) was a result of the anticipation that this group has worse arterial stiffening than other groups, and consequently more inefficient right ventricular-pulmonary vascular interactions, which account for their worse prognosis. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03523910
Study type Interventional
Source University of Wisconsin, Madison
Contact
Status Completed
Phase N/A
Start date April 25, 2012
Completion date February 13, 2017

See also
  Status Clinical Trial Phase
Recruiting NCT03145298 - ALlogeneic Cardiosphere-derived Stem Cells (CDCs) for Pulmonary Hypertension therApy Phase 1
Recruiting NCT03362047 - (RIGHT HEART III Study - Right Ventricular Hemodynamic Evaluation and Response to Treatment) Phase 2
Recruiting NCT01347216 - COMPERA / COMPERA-KIDS
Recruiting NCT03235401 - The PAH Disability and Bothersomeness Questionnaire N/A
Terminated NCT00586794 - Therapy of Pulmonary Arterial Hypertension (PAH) - Treatment With Sildenafil in Eisenmenger Patients Phase 3